The Cancer, Genome Atlas Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008, 455: 1061-1068. 10.1038/nature07385.
Article
Google Scholar
International Cancer Genome Consortium: International network of cancer genome projects. Nature. 2010, 464: 993-998. 10.1038/nature08987.
Article
Google Scholar
Zhang S, Liu CC, Li W, Shen H, Laird P, Zhou XJ: Discovery of multi-dimensional modules by integrative analysis of cancer genomic data. Nucleic Acids Res. 2012, 40: 9379-9391. 10.1093/nar/gks725.
Article
PubMed Central
PubMed
CAS
Google Scholar
Liu Z, Zhang XS, Zhang S: Breast tumour subgroups reveal diverse clinical predictive power. Sci Rep. 2014, 4: 4002-
PubMed
Google Scholar
Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O’Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, et al: Patterns of somatic mutation in human cancer genomes. Nature. 2007, 446: 153-158. 10.1038/nature05610.
Article
PubMed Central
PubMed
CAS
Google Scholar
Stratton MR, Campbell PJ, Futreal PA: The cancer genome. Nature. 2009, 458: 719-724. 10.1038/nature07943.
Article
PubMed Central
PubMed
CAS
Google Scholar
Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, Perner S, Prensner J, Debiasi RM, Demichelis F, Hatton C, Rubin MA, Garraway LA, Nelson SF, Liau L, Mischel PS, Cloughesy TF, Meyerson M, Golub TA, Lander ES, Mellinghoff IK, et al: Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci. 2007, 104: 20007-20012. 10.1073/pnas.0710052104.
Article
PubMed Central
PubMed
CAS
Google Scholar
Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, et al: Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008, 455: 1069-1075. 10.1038/nature07423.
Article
PubMed Central
PubMed
CAS
Google Scholar
Jones S, Zhang X, Parsons DW, Lin JCH, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, et al: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008, 321: 1801-1806. 10.1126/science.1164368.
Article
PubMed Central
PubMed
CAS
Google Scholar
Boca SM, Kinzler KW, Velculescu VE, Vogelstein B, Parmigiani G: Patient-oriented gene set analysis for cancer mutation data. Genome Biol. 2010, 11: R112-10.1186/gb-2010-11-11-r112.
Article
PubMed Central
PubMed
Google Scholar
Efroni S, Ben-Hamo R, Edmonson M, Greenblum S, Schaefer CF, Buetow KH: Detecting cancer gene networks characterized by recurrent genomic alterations in a population. PLoS ONE. 2011, 6: e14437-10.1371/journal.pone.0014437.
Article
PubMed Central
PubMed
CAS
Google Scholar
Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med. 2004, 10: 789-799. 10.1038/nm1087.
Article
PubMed
CAS
Google Scholar
Yeang CH, McCormick F, Levine A: Combinatorial patterns of somatic gene mutations in cancer. FASEB J. 2008, 22: 2605-2622. 10.1096/fj.08-108985.
Article
PubMed
CAS
Google Scholar
Ciriello G, Cerami E, Sander C, Schultz N: Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 2012, 22: 398-406. 10.1101/gr.125567.111.
Article
PubMed Central
PubMed
CAS
Google Scholar
Miller CA, Settle SH, Sulman EP, Aldape KD, Milosavljevic A: Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors. BMC Med Genomics. 2011, 4: 34-10.1186/1755-8794-4-34.
Article
PubMed Central
PubMed
Google Scholar
Zhang J, Zhang S, Wang Y, Zhang XS: Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data. BMC Syst Biol. 2013, 7: S4-
Article
PubMed Central
PubMed
Google Scholar
Acharya LR, Judeh T, Duan Z, Rabbat MG, Zhu D: GSGS: a computational approach to reconstruct signaling pathway structures from gene sets. IEEE/ACM Trans Comput Biol Bioinformatics. 2012, 9: 438-450.
Article
Google Scholar
Vandin F, Upfal E, Raphael BJ: De novo discovery of mutated driver pathways in cancer. Genome Res. 2012, 22: 375-385. 10.1101/gr.120477.111.
Article
PubMed Central
PubMed
CAS
Google Scholar
Zhao J, Zhang S, Wu LY, Zhang XS: Efficient methods for identifying mutated driver pathways in cancer. Bioinformatics. 2012, 28: 2940-2947. 10.1093/bioinformatics/bts564.
Article
PubMed
CAS
Google Scholar
Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144: 646-674. 10.1016/j.cell.2011.02.013.
Article
PubMed
CAS
Google Scholar
Cui Q, Ma Y, Jaramillo M, Bari H, Awan A, Yang S, Zhang S, Liu L, Lu M, O’Connor- McCourt M, Purisima EO, Wang E: A map of human cancer signaling. Mol Syst Biol. 2007, 3: 152-
Article
PubMed Central
PubMed
Google Scholar
Klijn C, Bot J, Adams DJ, Reinders M, Wessels L, Jonkers J: Identification of networks of co-occurring, tumor-related DNA copy number changes using a genome-wide scoring approach. PLoS Comput Biol. 2010, 6: e1000631-10.1371/journal.pcbi.1000631.
Article
PubMed Central
PubMed
Google Scholar
Kumar N, Rehrauer H, Cai H, Baudis M: Cdcoca: a statistical method to define complexity dependence of co-occuring chromosomal aberrations. BMC Med Genom. 2011, 4: 21-10.1186/1755-8794-4-21.
Article
Google Scholar
Forbes S, Clements J, Dawson E, Bamford S, Webb T, Dogan A, Flanagan A, Teague J, Wooster R, Futreal PA, Stratton MR: COSMIC 2005. Br J Cancer. 2006, 94: 318-322. 10.1038/sj.bjc.6602928.
Article
PubMed Central
PubMed
CAS
Google Scholar
Gu Y, Zhao W, Xia J, Zhang Y, Wu R, Wang C, Guo Z: Analysis of pathway mutation profiles highlights collaboration between cancer-associated superpathways. Hum Mutat. 2011, 32: 1028-1035. 10.1002/humu.21541.
Article
PubMed
CAS
Google Scholar
Gu Y, Wang H, Qin Y, Zhang Y, Zhao W, Qi L, Zhang Y, Wang C, Guo Z: Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma. Mol Biosyst. 2013, 9: 467-477. 10.1039/c2mb25528f.
Article
PubMed
CAS
Google Scholar
Gursky S, Olopade OI, Rowley JD: Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types. Cancer Genet Cytogenet. 2001, 129: 93-101. 10.1016/S0165-4608(01)00444-7.
Article
PubMed
CAS
Google Scholar
Christopher SA, Diegelman P, Porter CW, Kruger WD: Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res. 2002, 62: 6639-6644.
PubMed
CAS
Google Scholar
Wikman H, Nymark P, Vayrynen A, Jarmalaite S, Kallioniemi A, Salmenkivi K, Vainio-Siukola K, Husgafvel-Pursiainen K, Knuutila S, Wolf M, Anttila S: CDK4 is a probable target gene in a novel amplicon at 12q13.3- q14.1 in lung cancer. Gene Chromosome Cancer. 2005, 42: 193-199. 10.1002/gcc.20122.
Article
CAS
Google Scholar
Mays-Hoopes LL: Aging and cell division. Nat Educ. 2010, 3: 55-
Google Scholar
Campisis J: Cancer and ageing: rival demons?. Nat Rev Cancer. 2003, 3: 339-349. 10.1038/nrc1073.
Article
Google Scholar
Kabbarah O, Chin L: Advances in malignant melanoma: genetic insights from mouse and man. Front Biosci. 2006, 11: 928-942. 10.2741/1849.
Article
PubMed
CAS
Google Scholar
Rahrmann EP, Watson AL, Keng VW, Choi K, Moriarity BS, Beckmann DA, Wolf NK, Sarver A, Collins MH, Moertel CL, Wallace MR, Gel B, Serra E, Ratner N, Largaespada1 DA: Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet. 2013, 45: 756-766. 10.1038/ng.2641.
Article
PubMed Central
PubMed
CAS
Google Scholar
Chow LML, Endersby R, Zhu X, Rankin S, Qu C, Zhang J, Broniscer A, Ellison DW, Baker SJ: Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell. 2011, 19: 305-316. 10.1016/j.ccr.2011.01.039.
Article
PubMed Central
PubMed
CAS
Google Scholar
Xing F, Persaud Y, Pratilas CA, Taylor BS, Janakiraman M, She QB, Gallardo H, Liu C, Merghoub T, Hefter B, Dolgalev I, Viale A, Heguy A, De Stanchina E, Cobrinik D, Bollag G, Wolchok J, Houghton A, Solit DB: Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF. Oncogene. 2012, 31: 446-457. 10.1038/onc.2011.250.
Article
PubMed Central
PubMed
CAS
Google Scholar
Beckner ME, Patil S, LeBlanc JF, Katira K, Nanda A, Martin SS, Brunson LE, Truong LN, Nordberg ML: MLPA and REMBRANDT data predict potential modulation of vitamin D via increased CYP27B1 in aggressive primary brain tumors. Cancer Res. 2010, 70 (8 Suppl): Abstract 1573-
Article
Google Scholar
Chau YY, Hastie ND: The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis. Trends Genet. 2012, 28: 515-524. 10.1016/j.tig.2012.04.004.
Article
PubMed
CAS
Google Scholar
Kim MKH, McGarry TJ, Broin PO, Flatow JM, Golden AAJ, Licht JD: An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1. Proc Natl Acad Sci. 2009, 106: 11154-11159. 10.1073/pnas.0901591106.
Article
PubMed Central
PubMed
CAS
Google Scholar
Chehab NH, Malikzay A, Appel M, Halazonetis TD: Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53. Genes Dev. 2000, 14: 278-288.
PubMed Central
PubMed
CAS
Google Scholar
Greulich H: The genomics of lung adenocarcinoma: opportunities for targeted therapies. Genes cancer. 2010, 1: 1200-1210. 10.1177/1947601911407324.
Article
PubMed Central
PubMed
CAS
Google Scholar
Kesanakurti D, Chetty C, Rajasekhar Maddirela D, Gujrati M, Rao JS: Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma. Cell Death Dis. 2012, 3: e445-10.1038/cddis.2012.182.
Article
PubMed Central
PubMed
CAS
Google Scholar
Solomon H, Buganim Y, Kogan-Sakin I, Pomeraniec L, Assia Y, Madar S, Goldstein I, Brosh R, Kalo E, Beatus T, Goldfinger N, Rotter V: Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature. J Cell Sci. 2012, 125: 3144-3152. 10.1242/jcs.099663.
Article
PubMed
CAS
Google Scholar
Kosaka T, Yatabe Y, Onozato R, Kuwano H, Mitsudomi T: Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma. J Thorac Oncol. 2009, 4: 22-29. 10.1097/JTO.0b013e3181914111.
Article
PubMed
Google Scholar
Leeper NJ, Raiesdana A, Kojima Y, Kundu RK, Cheng H, Maegdefessel L, Toh R, Ahn GO, Ali ZA, Anderson DR, Miller CL, Roberts SC, Spin JM, de Almeida PE, Wu JC, Xu B, Cheng K, Quertermous M, Kundu S, Kortekaas KE, Berzin E, Downing KP, Dalman RL, Tsao PS, Schadt EE, Owens GK, Quertermous T: Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol. 2013, 33: e1-e10. 10.1161/ATVBAHA.112.300399.
Article
PubMed Central
PubMed
CAS
Google Scholar
Seräo NVL, Delfino KR, Southey BR, Beever JE, Rodriguez-Zas SL: Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med Genomics. 2011, 4: 49-10.1186/1755-8794-4-49.
Article
PubMed Central
PubMed
Google Scholar
The Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature. 2011, 474: 609-615. 10.1038/nature10166.
Article
PubMed Central
Google Scholar
Plisiecka-Halasa J, Karpinska G, Szymanska T, Ziolkowska I, Madry R, Timorek A, Debniak J, Ulanska M, Jedryka M, Chudecka-Glaz A, Klimek M, Rembiszewska A, Kraszewska E, Dybowski B, Markowska J, Emerich J, Pluzanska A, Goluda M, Rzepka-Gorska I, Urbanski K, Zielinski J, Stelmachow J, Chrabowska M, Kupryjanczyk J: P21WAF1,P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens. Ann Oncol. 2003, 14: 1078-1085. 10.1093/annonc/mdg299.
Article
PubMed
CAS
Google Scholar
Yeung SJ, Pan J, Lee MH: Roles of p53, Myc and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell Mol Life Sci. 2008, 65: 3981-3999. 10.1007/s00018-008-8224-x.
Article
PubMed
CAS
Google Scholar
Calcagno DQ, Freitas VM, Leal MF, de Souza CRT, Demachki S, Montenegro R, Assumpcao PP, Khayat AS, Smith MAC, dos Santos AKCR, Burbano RR: MYC, FBXW7andTP53copy number variation and expression in Gastric Cancer. BMC Gastroenterol. 2013, 13: 141-10.1186/1471-230X-13-141.
Article
PubMed Central
PubMed
Google Scholar
Kuhn E, Wu RC, Guan B, Wu G, Zhang J, Wang Y, Song L, Yuan X, Wei L, Roden RBS, Kuo KT, Nakayama K, Clarke B, Shaw P, Olvera N, Kurman RJ, Levine DA, Wang TL, Shih IM: Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J Natl Cancer Inst. 2012, 104: 1503-1513. 10.1093/jnci/djs345.
Article
PubMed Central
PubMed
CAS
Google Scholar
de Molina AR, Gallego-Ortega D, Sarmentero-Estrada J, Lagares D, del Pulgar TG, Eva Bandrés E, García-Foncillas J, Lacal JC: Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: Implications in cancer therapy. Int J Biochem Cell Biol. 2008, 40: 1753-1763. 10.1016/j.biocel.2008.01.013.
Article
Google Scholar
Sangha N, Wu R, Kuick R, Powers S, Mu D, Fiander D, Yuen K, Katabuchi H, Tashiro H, Fearon ER, Cho KR: Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. Neoplasia. 2008, 10: 1362-1372.
Article
PubMed Central
PubMed
CAS
Google Scholar
Zhang J, Shi Y, Lalonde E, Li L, Cavallone L, Ferenczy A, Gotlieb WH, Foulkes WD, Majewski J: Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient. BMC Cancer. 2013, 13: 146-10.1186/1471-2407-13-146.
Article
PubMed Central
PubMed
CAS
Google Scholar
Kalev P, Simicek M, Vazquez I, Munck S, Chen L, Soin T, Danda N, Chen W, Sablina A: Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition. Cancer Res. 2012, 72: 6414-6424. 10.1158/0008-5472.CAN-12-1667.
Article
PubMed
CAS
Google Scholar
Youn A, Simon R: Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations. BMC Bioinformatics. 2013, 14: 363-10.1186/1471-2105-14-363.
Article
PubMed Central
PubMed
Google Scholar
Leiserson MDM, Blokh D, Sharan R, Raphael BJ: Simultaneous identification of multiple driver pathways in cancer. PLoS Comput Biol. 2013, 9: e1003054-10.1371/journal.pcbi.1003054.
Article
PubMed Central
PubMed
CAS
Google Scholar